Business Context and Reporting Period
This Form 8-K filing by Nephros, Inc. (NEPH) covers the reporting period of September 1, 2021. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and personnel changes rather than financial performance data.
Material Changes
Effective September 1, 2021, the Company appointed Wes Lobo to the role of Chief Commercial Officer. Mr. Lobo previously served as Chief Marketing Officer since February 2021. In this expanded role, he will oversee all commercial strategy and operations, including sales, marketing, business development, product management, and customer service.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook statements, or specific risk factors. The primary event reported is the internal leadership restructuring to consolidate commercial functions under a single executive.
Investor Verification Checklist
- Verify the press release (Exhibit 99.1) for detailed biographical information on Wes Lobo.
- Confirm the effective date of the role change (September 1, 2021).
- Review subsequent filings for any impact of this leadership change on commercial strategy or financial results.